Skip to main content
MGTX logo

MGTX · MeiraGTx Holdings plc · Financials

Track MGTX — free
$10.69 +0.19 (+1.81%) At close · Oct 9
Market Cap
$1.03B
Shares
96.04M
Volume · Oct 9 523.43K Avg daily vol (3M) 788.28K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$81.39M +144.6%
FY2025 Revenue FY2019–FY2025
Net Income
-$114.2M +22.7%
FY2025 Net Income FY2017–FY2025
Operating Margin
-130.2% +363.2pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$1.42 +33%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$46.36M +55.6%
FY2025 Operating Cash Flow FY2017–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
$397.5M $81.39M $33.28M $14.02M $15.92M $37.7M $15.56M $13.29M — —
$153.16M $129.62M $119.48M $103.79M $85.73M $66.69M $33.91M $24.88M $33.62M $22.36M
$3.66M $4.84M $23.79M — — — — — — —
$52.16M $52.9M $54.22M $47.29M $46.55M $43.77M $44.21M $46.68M $44.48M $9.33M
— — — — $200K $300K $20K $0 — —
$12.1M $12.54M $12.83M $13.73M $8.72M $7.87M $4.17M $2.24M — —
$213.47M $187.36M $197.49M $151.08M $132.28M $110.46M $78.12M $71.56M $78.1M $31.68M
$184.03M -$105.97M -$164.21M -$137.06M -$116.36M -$72.76M -$62.55M -$58.27M -$78.1M -$31.68M
— -130.2% -493.44% -977.82% -730.87% -192.99% -401.94% -438.37% — —
$196.13M -$93.43M -$151.38M -$123.33M -$107.63M -$64.89M -$58.38M -$56.03M — —
$12.48M $12.2M $13.27M $13.25M $4.95M $288K $139K $48.61K $33.43K $42.86K
$1.33M $1.82M $4.15M $2.27M $777K $212K $1.28M $370.6K $53.41K $26.07K
— -$114.2M -$147.79M -$84.03M -$129.62M -$79.56M -$57.99M -$54.75M -$83.34M -$31.04M
$2.36M $0 $0 $0 — $0 $0 $0 -$474.39K $0
$78.98M -$114.2M -$147.79M -$84.03M -$129.62M -$79.56M -$57.99M -$54.75M -$82.87M -$31.04M
— -140.31% -444.1% -599.46% -814.16% -211.03% -372.63% -411.87% — —
$78.98M -$114.2M -$147.79M -$84.03M -$129.62M -$79.56M -$57.99M -$54.75M -$84.67M -$31.85M
$89.71M -$108.08M -$150.08M -$91.51M -$120.9M -$77.34M -$61.1M -$56.83M -$80.55M -$32.41M
USD/shares $0.76 -$1.42 -$2.12 -$1.49 -$2.87 -$1.80 -$1.54 — — —
USD/shares $0.71 -$1.42 -$2.12 -$1.49 -$2.87 -$1.80 -$1.54 — — —
shares — 80.43M 69.82M 56.49M 45.18M 44.14M 37.72M 33.16M 18.95M 8.57M
shares — 80.43M 69.82M 56.49M 45.18M 44.14M 37.72M 33.16M 18.95M 8.57M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Finance lease liabilities 2026-06-30 USD 125,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current finance lease liabilities
USD 40,000
Noncurrent finance lease liabilities
USD 85,000
Noncurrent notes payable 2026-06-30 USD 100,000,000 10-Q filed 2026-08-13
Operating lease liabilities 2026-06-30 USD 12,196,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 2,260,000
Noncurrent operating lease liabilities
USD 9,936,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 7.56×
EV/EBIT
—
Peer median 10.61×
P/E (TTM)
15.06×
Peer median 13.94×

Peer medians compare against the 279 similar-size Biotechnology companies (of 531 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024
License $74,991,000 —
Related Party Service Revenue $6,400,000 $33,279,000
Key facts CIK 1735438 CUSIP G59665102 13F (30d) 5 filings 5 filers Visit website Investor relations